Literature DB >> 7029225

Methicillin-resistant Staphylococcus aureus bacteraemia.

M McDonald, A Hurse, K N Sim.   

Abstract

Twenty-eight (53%) of 53 hospital-acquired staphylococcal bacteraemias which occurred at The Royal Melbourne Hospital over a two-year period were due to methicillin-resistant Staphylococcus aureus (MRSA). Every patient with MRSA bacteraemia had a significant underlying condition predisposing to nosocomial sepsis, and each had an intravascular foreign body in situ at the time. Most were being nursed in special care areas of the hospital and had been exposed to multiple or broad-spectrum antibiotics during the month before development of bacteraemia. Patients acquiring MRSA infection should be isolated and, when the diagnosis of bacteraemia is considered, any potential primary focus should be removed. Vancomycin is the drug of choice in life-threatening MRSA infections.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7029225     DOI: 10.5694/j.1326-5377.1981.tb100894.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  8 in total

1.  Staying one jump ahead of resistant Staphylococcus aureus.

Authors:  P J Sanderson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-06

Review 2.  Severe infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  C T Keane; M T Cafferkey
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

3.  Common bacterial pathogens and resistance to antibiotics.

Authors:  P J Sanderson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-15

4.  Analysis of plasmids in nosocomial strains of multiple-antibiotic-resistant Staphylococcus aureus.

Authors:  B R Lyon; J W May; R A Skurray
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

5.  Antimicrobial chemotherapy of septicemia due to methicillin-resistant Staphylococcus aureus.

Authors:  M T Cafferkey; R Hone; C T Keane
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

6.  Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.

Authors:  J P Maskell; A M Sefton; J Yong; S J Chi; J D Williams
Journal:  Infection       Date:  1988       Impact factor: 3.553

7.  Activity of coumermycin against clinical isolates of staphylococci.

Authors:  M N Guillemin; H M Miles; M I McDonald
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

8.  Cloning, expression, purification, crystallization and preliminary X-ray diffraction studies of N-acetylneuraminate lyase from methicillin-resistant Staphylococcus aureus.

Authors:  Rachel A North; Sarah A Kessans; Sarah C Atkinson; Hironori Suzuki; Andrew J A Watson; Benjamin R Burgess; Lauren M Angley; André O Hudson; Arvind Varsani; Michael D W Griffin; Antony J Fairbanks; Renwick C J Dobson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-02-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.